Parkinsonism: An emerging post COVID sequelae
Abhijith Rajaram Rao, Shaik Mohammed Hidayathullah, Karan Hegde, Prabha Adhikari
Abstract
Parkinsonism has a complex and multifactorial aetiology and the role of post viral infection parkinsonism has been documented. The recent pandemic has made it clear that COVID-19 causes respiratory disease and affects multiple organs, which includes the central nervous system. Here we report three cases of post COVID parkinsonism occurring in older adults, age 60 years and above, and their response to levodopa-carbidopa.
Topics & Concepts
ParkinsonismMedicinePandemicCoronavirus disease 2019 (COVID-19)EtiologyLevodopaCarbidopaDiseaseRespiratory systemParkinson's disease2019-20 coronavirus outbreakIntensive care medicinePediatricsCentral nervous systemPathologyInternal medicineInfectious disease (medical specialty)OutbreakLong-Term Effects of COVID-19Parkinson's Disease Mechanisms and TreatmentsNeuroinflammation and Neurodegeneration Mechanisms